Index of reports
> Cases with Drug Interaction (14)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cubicin (Daptomycin) where reactions include drug interaction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cubicin side effects in 63 year old male
Reported by a physician from United States on 2012-08-06
Patient: 63 year old male
Reactions: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Aspartate Aminotransferase Increased, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Crestor
Administration route: Oral
Indication: Acute Respiratory Distress Syndrome
Start date: 2012-04-19
End date: 2012-04-19
Cubicin
Dosage: 200ml/hour, 580mg
Start date: 2012-05-02
End date: 2012-05-02
Crestor
Administration route: Oral
Indication: Sepsis
Start date: 2012-04-19
End date: 2012-04-19
Crestor
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-01
Crestor
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-01
Cubicin
Dosage: 200ml/hour, 580mg
Start date: 2012-04-30
End date: 2012-04-30
Other drugs received by patient: Lactulose; Albumin (Human); Diuril; Flagyl; Vancomycin; Meropenem; Ferrous Sulfate and Folic Acid; Casofungin; Atrovent; Levlbuterol; Levofloxacin
Possible Cubicin side effects in 63 year old male
Reported by a physician on 2012-08-06
Patient: 63 year old male
Reactions: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Refractory Anaemia, Haemorrhage, Hypotension, Aspartate Aminotransferase Increased, Drug Interaction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cubicin
Start date: 2012-05-02
End date: 2012-05-02
Rosuvastatin
Administration route: Oral
Start date: 2012-04-19
End date: 2012-04-19
Rosuvastatin
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-30
Cubicin
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-30
End date: 2012-04-30
Other drugs received by patient: Levalbuterol Hydrochloride; Vancomycin; Meropenem; Chlorothiazide; Lactulose; Ferrous Sulfate TAB; Caspofungin Acetate; Flagyl; Albumin (Human); Atrovent; Levofloxacin
Possible Cubicin side effects in 63 year old male
Reported by a physician on 2012-08-01
Patient: 63 year old male
Reactions: Rhabdomyolysis, Refractory Anaemia, Blood Creatine Phosphokinase Increased, Haemorrhage, Aspartate Aminotransferase Increased, Hypotension, Drug Interaction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cubicin
Start date: 2012-05-02
End date: 2012-05-02
Cubicin
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-30
End date: 2012-04-30
Rosuvastatin
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-30
Rosuvastatin
Administration route: Oral
Start date: 2012-04-19
End date: 2012-04-19
Other drugs received by patient: Chlorothiazide; Atrovent; Meropenem; Levofloxacin; Levalbuterol Hydrochloride; Flagyl; Albumin (Human); Caspofungin Acetate; Lactulose; Vancomycin; Ferrous Sulfate TAB
Possible Cubicin side effects in 63 year old male
Reported by a physician from United States on 2012-07-26
Patient: 63 year old male
Reactions: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Aspartate Aminotransferase Increased, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Crestor
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-01
Cubicin
Dosage: 200ml/hour, 580mg
Start date: 2012-04-30
End date: 2012-04-30
Crestor
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-01
Crestor
Administration route: Oral
Indication: Sepsis
Start date: 2012-04-19
End date: 2012-04-19
Crestor
Administration route: Oral
Indication: Acute Respiratory Distress Syndrome
Start date: 2012-04-19
End date: 2012-04-19
Cubicin
Dosage: 200ml/hour, 580mg
Start date: 2012-05-02
End date: 2012-05-02
Other drugs received by patient: Flagyl; Vancomycin; Levlbuterol; Atrovent; Meropenem; Casofungin; Diuril; Albumin (Human); Ferrous Sulfate and Folic Acid; Lactulose; Levofloxacin
Possible Cubicin side effects in 63 year old male
Reported by a physician on 2012-05-25
Patient: 63 year old male
Reactions: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Aspartate Aminotransferase Increased, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cubicin
Dosage: dose unit:u
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-30
End date: 2012-05-02
Rosuvastatin
Administration route: Oral
Start date: 2012-04-19
End date: 2012-04-19
Rosuvastatin
Administration route: Oral
Start date: 2012-04-20
End date: 2012-05-30
Other drugs received by patient: Ferrous Sulfate TAB; Lactulose; Flagyl; Atrovent; Vancomycin; Caspofungin Acetate; Chlorothiazide; Meropenem; Albumin (Human); Levalbuterol Hydrochloride; Levofloxacin
Possible Cubicin side effects in 48 year old male
Reported by a physician from Spain on 2012-04-18
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis, Drug Interaction
Drug(s) suspected as cause:
Furosemide
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Meropenem
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Acetaminophen
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Enoxaparin Sodium
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Dexchlorpheniramine Maleate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Omeprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Acyclovir
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Lactulose
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Cefepime
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Noxafil
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Urokinase
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Tazobactam
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Allopurinol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Cloxacillin Sodium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Levofloxacin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Targocid
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Cubicin
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Amphotericin B
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Hibor
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Possible Cubicin side effects in 48 year old male
Reported by a pharmacist from Spain on 2012-04-13
Patient: 48 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Myositis, Drug Interaction
Drug(s) suspected as cause:
Acyclovir
Dosage: 500 mg;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-11
End date: 2011-09-13
Hibor (Heparin Sodium / 00027704 / )
Dosage: 2500 iu;qd;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-07
End date: 2011-09-30
Abbokinase
Dosage: 100 kiu;qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-15
End date: 2011-09-15
Omeprazole
Dosage: 20 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-10-07
Allopurinol
Dosage: 300 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Enoxaparin Sodium
Dosage: 20 mg;qd;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-08-26
Meropenem
Dosage: 1 mg;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-05
End date: 2011-09-14
Levofloxacine (Levofloxacin)
Dosage: 500 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-18
End date: 2011-09-28
Orbenin (Cloxacillin Sodium)
Dosage: 1000 mg;qid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-16
Duphalac
Dosage: 10 gm;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-31
End date: 2011-09-14
Targocid
Dosage: 400 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-06
End date: 2011-09-19
Polaramine
Dosage: 12 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-22
Ambisome
Dosage: 250 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-16
End date: 2011-09-26
Noxafil
Dosage: po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-02
End date: 2011-09-17
Acetaminophen
Dosage: 1 gm;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-08
Furosemide
Dosage: 20 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-08
End date: 2011-09-26
Cubicin
Dosage: 350 mg;qd;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-10
End date: 2011-09-14
Maxipime
Dosage: 1 gm;tid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-25
End date: 2011-09-03
Tazocel (Pip / Tazo)
Dosage: 1 gm;qid;iv
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-14
End date: 2011-09-19
Vesanoid
Dosage: 50 mg;bid;po
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2011-08-26
End date: 2011-10-07
Possible Cubicin side effects in 90 year old male
Reported by a physician from Japan on 2012-03-28
Patient: 90 year old male
Reactions: Activated Partial Thromboplastin Time Prolonged, Drug Interaction, Prothrombin Time Prolonged
Drug(s) suspected as cause:
Cubicin
Dosage: daily dosage unknown
Indication: Staphylococcal Infection
Start date: 2012-01-30
End date: 2012-01-31
Warfarin Sodium
Dosage: daily dosage unknown
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-26
Possible Cubicin side effects in 12 year old female
Reported by a individual with unspecified qualification from France on 2012-03-19
Patient: 12 year old female, weighing 40.5 kg (89.1 pounds)
Reactions: Sepsis, Drug Interaction, Toxicity To Various Agents
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cubicin
Dosage: dose unit:u unknown
Indication: Sepsis
Start date: 2012-01-01
End date: 2012-01-21
Etoposide
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-16
End date: 2012-01-01
Methotrexate
Dosage: dose unit:17
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-21
End date: 2012-01-19
Other drugs received by patient: Luride; Plitican; Zantac; Gentamicin; Zoledronoc Acid; Cyclophosphamide; Phosphorus; Ifosfamide; ALL Other Therapeutic Products; ALL Other Therapeutic Products; Zyvox; Calcium Carbonate; Piperacillin and Tazobactam; Targocid; Vancomycin; Morphine Sulfate; Atarax / 00595201 /; Mesna; Ergocalciferol; Acetaminophen; Calcium Folinate
Possible Cubicin side effects in 90 year old male
Reported by a physician from Japan on 2012-03-12
Patient: 90 year old male
Reactions: Activated Partial Thromboplastin Time Prolonged, Drug Interaction, Prothrombin Time Prolonged
Drug(s) suspected as cause:
Cubicin
Dosage: daily dosage unknown
Indication: Staphylococcal Infection
Start date: 2012-01-30
End date: 2012-01-31
Warfarin Sodium
Dosage: daily dosage unknown
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-26
Possible Cubicin side effects in 90 year old male
Reported by a consumer/non-health professional from United States on 2012-03-12
Patient: 90 year old male
Reactions: Activated Partial Thromboplastin Time Prolonged, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Drug Interaction, Prothrombin Time Prolonged
Drug(s) suspected as cause:
Cubicin
Dosage: 350 mg, qd
Indication: Staphylococcal Infection
Start date: 2012-01-30
End date: 2012-01-31
Warfarin Sodium
Dosage: 2 mg, qd
Administration route: Oral
End date: 2012-01-26
Possible Cubicin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13
Patient:
Reactions: Trismus, Drug Interaction
Drug(s) suspected as cause:
Invanz
Dosage: dose unit:u unknown
Indication: Product Used FOR Unknown Indication
Cubicin
Dosage: dose unit:u unknown
Indication: Product Used FOR Unknown Indication
Possible Cubicin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13
Patient:
Reactions: Trismus, Drug Interaction
Drug(s) suspected as cause:
Invanz
Dosage: dose unit:u unknown
Indication: Product Used FOR Unknown Indication
Cubicin
Dosage: dose unit:u unknown
Indication: Product Used FOR Unknown Indication
Possible Cubicin side effects in 69 year old male
Reported by a physician from United States on 2011-11-11
Patient: 69 year old male, weighing 133.0 kg (292.6 pounds)
Reactions: Rhabdomyolysis, Drug Interaction, Blood Potassium Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cubicin
Cubicin
Simvastatin
Indication: Product Used FOR Unknown Indication
Cubicin
Cubicin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Levofloxacin; Gentamicin; Vancomycin; Cefepime
|